Company Overview and News

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

Headline News

ICUI / ICU Medical, Inc. / HENDERSON GROUP PLC - JANUS HENDERSON GROUP OWNS OVER 5% (Passive Investment)

2018-02-12 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Amendment No.: 0* Name of Issuer: ICU MEDICAL, INC. Title of Class of Securities: Common Stock CUSIP Number: 44930G107 Date of Event Which Requires Filing of this Statement: 12/31/2017 Check the appropriate box to designate the rule pursuant to which this Schedule is filed.

ICUI / ICU Medical, Inc. / HENDERSON GROUP PLC - JANUS HENDERSON GROUP OWNS OVER 5% (Passive Investment)

2018-02-12 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Amendment No.: 0* Name of Issuer: ICU MEDICAL, INC. Title of Class of Securities: Common Stock CUSIP Number: 44930G107 Date of Event Which Requires Filing of this Statement: 12/31/2017 Check the appropriate box to designate the rule pursuant to which this Schedule is filed.

ICUI / ICU Medical, Inc. / VANGUARD GROUP INC - 3G/A (Passive Investment)

2018-02-09 sec.gov
icumedicalinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Schedule 13G   Under the Securities Exchange Act of 1934 (Amendment No.: 5 )*       Name of issuer:  ICU Medical Inc     Title of Class of Securities:  Common Stock     CUSIP Number:  44930G107     Date of Event Which Requires Filing of this Statement: December 31, 2017   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:   (X) Rule 13d-

ICUI / ICU Medical, Inc. / VANGUARD GROUP INC - 3G/A (Passive Investment)

2018-02-09 sec.gov
icumedicalinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Schedule 13G   Under the Securities Exchange Act of 1934 (Amendment No.: 5 )*       Name of issuer:  ICU Medical Inc     Title of Class of Securities:  Common Stock     CUSIP Number:  44930G107     Date of Event Which Requires Filing of this Statement: December 31, 2017   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:   (X) Rule 13d-

Pfizer (PFE) Stock Falls Despite Q4 Earnings & Sales Beat

2018-01-30 zacks
Pfizer, Inc. (PFE - Free Report) reported fourth-quarter 2017 adjusted earnings per share of 62 cents, which beat the Zacks Consensus Estimate of 56 cents by 10.7%. Earnings also rose 32% year over year driven by higher international sales and lower costs and share count. (81-0)

ICUI / ICU Medical, Inc. - Stock Institutional Ownership and Shareholders - Fintel.io

2018-01-25 fintel.io
ICU Medical, Inc. (NASDAQ:ICUI) has 222 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 15,869,217 shares. Largest shareholders include BlackRock Inc., Henderson Group Plc, Vanguard Group Inc, Wells Fargo & Company/mn, Wellington Management Group Llp, GW&K Investment Management, LLC, Renaissance Technologies LLC, JP Morgan Chase & Co, Silvercrest Asset Management Group Llc, and State Street Corp. (75-0)

ICUI / ICU Medical, Inc. / BlackRock Inc. - 3G/A (Passive Investment)

2018-01-25 sec.gov
us44930g1076_012418.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 9) ICU MEDICAL INC -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 44930G107 -------------------------------------------------------- (CUSIP Number) December 31, 2017 ------------------------------------------------------

ICUI / ICU Medical, Inc. / BlackRock Inc. - 3G/A (Passive Investment)

2018-01-25 sec.gov
us44930g1076_012418.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 9) ICU MEDICAL INC -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 44930G107 -------------------------------------------------------- (CUSIP Number) December 31, 2017 ------------------------------------------------------

ICUI / ICU Medical, Inc. 8-K 2017 1.5.17 ITEM 5.02 (Current Report)

2018-01-05 sec.gov
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549  FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 4, 2018 ICU MEDICAL, INC. (Exact name of registrant as specified in its charter) DELAWARE   001-34634   33-0022692 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.

Hold On To Pfizer In 2018

2017-12-29 seekingalpha
Pfizer expects robust revenue growth for its biosimilars  as well as emerging markets portfolio in 2017. (14-0)

Product Innovation Drives Illumina, Downbeat Margins a Woe

2017-12-27 zacks
On Dec 26, we issued an updated research report on Illumina, Inc. (ILMN - Free Report) . The stock carries a Zacks Rank #3 (Hold). (59-0)

PRA Health (PRAH) Hits 52-Week High on Multiple Positives

2017-12-26 zacks
Shares of PRA Health Sciences, Inc. (PRAH - Free Report) rallied to a new 52-week high of $92 on Dec 22, closing the session nominally lower at $91.53. This represents a strong year-to-date return of approximately 23.9%, higher than the S&P 500’s 6.8%. The stock sports a Zacks Rank #1 (Strong Buy). Taking the stable stock performance into consideration, we expect PRA Health stock to scale new highs in the quarters ahead. (68-0)

Zimmer Biomet Suffers a Dull Knee Business & Supply Delay

2017-12-26 zacks
On Dec 22, we issued an updated research report on Warsaw, IN-based Zimmer Biomet Holdings Inc. (ZBH - Free Report) . The company carries a Zacks Rank #4 (Sell). (75-0)

Small-Cap Growth ETF (JSML) Hits New 52-Week High

2017-12-21 zacks
For investors seeking momentum, Small Cap Growth Alpha ETF (JSML - Free Report) is probably on radar now. The fund just hit a 52-week high and is up more than 23% from its 52-week low price of $30.00/share. (36-0)

BRIEF-Medical Australia says court approved ICU Medical's offer to buy co

2017-11-17 reuters
* Federal Court of Australia approves scheme of arrangement under which ICU Medical Inc to buy all shares on issue in MLA​ (1-0)


CUSIP: 44930G107